Tuberculosis and systemic illnesses: 16 cases;Tuberculose maladie et maladies systemiques. A propos de 16 cas

Revue de Medecine Interne

Volumn 19, Issue 2, 1998, Pages 91-97

  Darras Joly, C ^a   Wechsler, B ^a   Bletry O ^b   Du, Le Thi Huong ^a   Raguin, G ^c   Godeau, P ^a   Piette, J C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b FOCH HOSPITAL   (France)

^c GROUPE HOSPITALIER DIACONESSES CROIX SAINT SIMON   (France)

Author keywords

Corticosteroid therapy; Immunosuppression; Tuberculosis

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LUNG TUBERCULOSIS; LYMPHADENITIS; MALE; MILIARY TUBERCULOSIS; STEROID THERAPY; TUBERCULOSIS; COMPARATIVE STUDY; CONNECTIVE TISSUE DISEASE; FOLLOW UP; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDY; TUBERCULOUS LYMPHADENITIS; VASCULITIS;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; CONNECTIVE TISSUE DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TUBERCULOSIS; TUBERCULOSIS, LYMPH NODE; TUBERCULOSIS, PULMONARY; VASCULITIS;

EID: 0032005059     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(97)83418-2     Document Type: Article

References (18)

1. 1 Haury B, Salomon J. Épidémiologie de la tuberculose en France en 1994. Méd Mal Infect 1995 ; 25 : 281-90
2. 2 Skogberg K, Ruutu P, Tukiainen P, Valtonen V. Effect of immunosuppressive therapy on the clinical presentation and outcome of tuberculosis. Clin Infect Dis 1993 ; 17 : 1012-7
3. 3 Millar JW, Horne NW. Tuberculosis in immunosuppressed patients. Lancet 1979 ; i : 1176-8
4. 4 Dautzenberg B, Grosset J, Fechner J, Lucciani J, Debré P, Herson S et al. The management of thirty immunocompromised patients with tuberculosis. Am Rev Respir Dis 1984 ; 129 : 494-6
5. 5 Feng PH, Tan TH. Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis 1982 ; 41 : 11-4
6. 6 Garcia-Leoni ME, Martin-Scarpa C, Rodeno P, Valderrabano F, Moreno S, Bouza E. High incidence of tuberculosis in renal patients. Eur J Clin Microbiol Infect Dis 1990 ; 9 : 283-5
7. 7 Miller RA, Lanza LA, Kline JN, Geist LJ. Mycobacterium tuberculosis in lung transplant recipient. Am J Respir Crit Care Med 1995; 152: 374-6
8. 8 Hall CM, Willcox PA, Swanepoel CR, Kahn D, Van Zyl Smit R. Mycobacterial infection in renal transplant recipient. Chest 1994; 106: 435-9
9. 9 Meyers BR, Halpern M, Sheiner P, Mendelson MH, Neibart E, Miller C. Tuberculosis in liver transplant patients. Transplantation 1994; 58 : 301-6
10. 10 Dannenberg AM. Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev Infect Dis 1989 ; 11 (suppl 2) ; S369-78
11. 11 Jones BE, Young SMM, Antoniskis D, Davidson PT, Kramer F, Barnes F. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993 ; 148 : 1292-7
12. 12 Haas DW, Des Prez RM. Mycobacterium tuberculosis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. Harlow: Churchill Livingstone; 1995. p 2213-43
13. 13 Hong Kong Chest Service. Tuberculosis Research Center, Madras, British Medical Research Center. A double-blind placebo-controlled clinical trial at 3 antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis 192; 145 : 36-41
14. 14 Union internationale contre la tuberculose. Comité de prophylaxie. Efficacy of various durations of isoniazide preventive therapy for tuberculosis: five years of follow up in the IUAT trial. Bull WHO 1982 ; 60 : 555-64
15. 15 Geiter LJ, O'Brien RJ. Conference on new approaches for tuberculosis preventive therapy. J Infect Dis 1987 ; 156 : 536-7
16. 16 Geiter LJ, O'Brien RJ, Kopanoff DE. Short-course preventive therapy. Am Rev Respir Dis 1990 ; 14 : A437
17. 17 Bitaudeau P, Clément S, Chartier JP, Papapietro PM, Bonnafoux A, Arnaud M et al. Interaction rifampicine-prednisolone. À propos de 2 cas au cours d'une maladie de Horton. Rev Rhum 1989 ; 56 : 87-8
18. 18 Mc Allister W, Thompson PJ, Al-Habet SM, Rogers HJ. Rifampicin reduces effectiveness and biavailability of prednisolone. Br Med J 1983; 286: 923-5